204 related articles for article (PubMed ID: 18315950)
21. Chemotaxis and transendothelial migration of CD34(+) hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1.
Bautz F; Denzlinger C; Kanz L; Möhle R
Blood; 2001 Jun; 97(11):3433-40. PubMed ID: 11369634
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.
Walch L; Norel X; Bäck M; Gascard JP; Dahlén SE; Brink C
Br J Pharmacol; 2002 Dec; 137(8):1339-45. PubMed ID: 12466244
[TBL] [Abstract][Full Text] [Related]
23. Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils.
Bandeira-Melo C; Hall JC; Penrose JF; Weller PF
J Allergy Clin Immunol; 2002 Jun; 109(6):975-9. PubMed ID: 12063527
[TBL] [Abstract][Full Text] [Related]
24. Leukotriene C
Fujimori K; Uno S; Kuroda K; Matsumoto C; Maehara T
Biochim Biophys Acta Mol Cell Res; 2022 Mar; 1869(3):119203. PubMed ID: 34968576
[TBL] [Abstract][Full Text] [Related]
25. Tissue distribution and functional correlation of [3H]leukotriene C4 and [3H]leukotriene D4 binding sites in guinea-pig uterus and lung preparations.
Cheng JB; Lang D; Bewtra A; Townley RG
J Pharmacol Exp Ther; 1985 Jan; 232(1):80-7. PubMed ID: 2981321
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the human cysteinyl leukotriene CysLT1 receptor.
Lynch KR; O'Neill GP; Liu Q; Im DS; Sawyer N; Metters KM; Coulombe N; Abramovitz M; Figueroa DJ; Zeng Z; Connolly BM; Bai C; Austin CP; Chateauneuf A; Stocco R; Greig GM; Kargman S; Hooks SB; Hosfield E; Williams DL; Ford-Hutchinson AW; Caskey CT; Evans JF
Nature; 1999 Jun; 399(6738):789-93. PubMed ID: 10391245
[TBL] [Abstract][Full Text] [Related]
27. Functional characterization of receptors for cysteinyl-leukotrienes in sheep trachealis muscle.
Jonsson EW
Pulm Pharmacol Ther; 1997; 10(1):29-36. PubMed ID: 9344830
[TBL] [Abstract][Full Text] [Related]
28. Effects of ONO-6950, a novel dual cysteinyl leukotriene 1 and 2 receptors antagonist, in a guinea pig model of asthma.
Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; inoue A; Nakao T; Nomura H; Murata M; Nakao S; Nambu F; Fujita M; Nakade S; Kawabata K
Eur J Pharmacol; 2015 Oct; 765():242-8. PubMed ID: 26318198
[TBL] [Abstract][Full Text] [Related]
29. Activation of CysLT receptors induces astrocyte proliferation and death after oxygen-glucose deprivation.
Huang XJ; Zhang WP; Li CT; Shi WZ; Fang SH; Lu YB; Chen Z; Wei EQ
Glia; 2008 Jan; 56(1):27-37. PubMed ID: 17910051
[TBL] [Abstract][Full Text] [Related]
30. Neutralization of leukotriene C4 and D4 activity by monoclonal and single-chain antibodies.
Kawakami Y; Hirano S; Kinoshita M; Otsuki A; Suzuki-Yamamoto T; Suzuki M; Kimoto M; Sasabe S; Fukushima M; Kishimoto K; Izumi T; Oga T; Narumiya S; Sugahara M; Miyano M; Yamamoto S; Takahashi Y
Biochim Biophys Acta; 2014 Jun; 1840(6):1625-33. PubMed ID: 24361619
[TBL] [Abstract][Full Text] [Related]
31. Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody.
Underwood DC; Osborn RR; Newsholme SJ; Torphy TJ; Hay DW
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):850-7. PubMed ID: 8887574
[TBL] [Abstract][Full Text] [Related]
32. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
[TBL] [Abstract][Full Text] [Related]
33. The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor.
Takasaki J; Kamohara M; Matsumoto M; Saito T; Sugimoto T; Ohishi T; Ishii H; Ota T; Nishikawa T; Kawai Y; Masuho Y; Isogai T; Suzuki Y; Sugano S; Furuichi K
Biochem Biophys Res Commun; 2000 Aug; 274(2):316-22. PubMed ID: 10913337
[TBL] [Abstract][Full Text] [Related]
34. Antagonist resistant contractions of the porcine pulmonary artery by cysteinyl-leukotrienes.
Bäck M; Norel X; Walch L; Gascard J; Mazmanian G; Dahlén S; Brink C
Eur J Pharmacol; 2000 Aug; 401(3):381-8. PubMed ID: 10936497
[TBL] [Abstract][Full Text] [Related]
35. Cysteinyl leukotriene receptor assays.
Muccitelli RM; Luttmann MA; Hay DW
Curr Protoc Pharmacol; 2001 May; Chapter 4():Unit 4.16. PubMed ID: 22293965
[TBL] [Abstract][Full Text] [Related]
36. Leukotriene D4 increases the excitability of capsaicin-sensitive nasal sensory nerves to electrical and chemical stimuli.
Taylor-Clark TE; Nassenstein C; Undem BJ
Br J Pharmacol; 2008 Jul; 154(6):1359-68. PubMed ID: 18500362
[TBL] [Abstract][Full Text] [Related]
37. CysLT
Sekioka T; Kadode M; Yonetomi Y; Kamiya A; Fujita M; Nabe T; Kawabata K
Eur J Pharmacol; 2017 Jan; 794():147-153. PubMed ID: 27887950
[TBL] [Abstract][Full Text] [Related]
38. Agonist- and T(H)2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes.
Shirasaki H; Seki N; Fujita M; Kikuchi M; Kanaizumi E; Watanabe K; Himi T
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):340-7. PubMed ID: 17941281
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.
Wunder F; Tinel H; Kast R; Geerts A; Becker EM; Kolkhof P; Hütter J; Ergüden J; Härter M
Br J Pharmacol; 2010 May; 160(2):399-409. PubMed ID: 20423349
[TBL] [Abstract][Full Text] [Related]
40. Leukotriene D
Liu T; Barrett NA; Nagai J; Lai J; Feng C; Boyce JA
J Allergy Clin Immunol; 2021 Jul; 148(1):195-208.e5. PubMed ID: 33285161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
